Index by author

01 March 2009; volume 33, issue 3

A

  1. Aguirre-Jaime, A.

    1. de Torres, J. P. et al "Sex differences in mortality in patients with COPD." European Respiratory Journal 33.3 (2009): 528-535. Web. 11 May. 2021.

  2. Alobid, I.

    1. Pujols, L. et al "Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo." European Respiratory Journal 33.3 (2009): 502-508. Web. 11 May. 2021.

  3. Anderson, J. A.

    1. Keene, O. N. et al "Lung function decline in COPD trials." European Respiratory Journal 33.3 (2009): 708-709. Web. 11 May. 2021.

  4. Antoniak, M.

    1. Fogarty, A. W. et al "A natural experiment on the impact of fruit supplementation on asthma symptoms in children." European Respiratory Journal 33.3 (2009): 481-485. Web. 11 May. 2021.

  5. Arshad, S. H.

    1. Scott, M. et al "Understanding the nature and outcome of childhood wheezing." European Respiratory Journal 33.3 (2009): 700-701. Web. 11 May. 2021.

  6. Ayers, L.

    1. Ayers, L. et al "Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea." European Respiratory Journal 33.3 (2009): 574-580. Web. 11 May. 2021.

B

  1. Baraldi, E.

    1. Gappa, M. et al "Paediatric HERMES: update of the European Training Syllabus for Paediatric Respiratory Medicine." European Respiratory Journal 33.3 (2009): 464-465. Web. 11 May. 2021.

  2. Baró, E.

    1. Miravitlles, M. et al "Validation of the COPD severity score for use in primary care: the NEREA study." European Respiratory Journal 33.3 (2009): 519-527. Web. 11 May. 2021.

  3. Barriga, P.

    1. Champagne, K. et al "Obstructive sleep apnoea and its association with gestational hypertension." European Respiratory Journal 33.3 (2009): 559-565. Web. 11 May. 2021.

  4. Barry, L.

    1. Weir, K. et al "Clinical signs and symptoms of oropharyngeal aspiration and dysphagia in children." European Respiratory Journal 33.3 (2009): 604-611. Web. 11 May. 2021.

  5. Bartalesi, F.

    1. Bartalesi, F. et al "QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases." European Respiratory Journal 33.3 (2009): 586-593. Web. 11 May. 2021.

  6. Bartoloni, A.

    1. Bartalesi, F. et al "QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases." European Respiratory Journal 33.3 (2009): 586-593. Web. 11 May. 2021.

  7. Becker, L.

    1. Mühlfeld, C. et al "Pre-ischaemic exogenous surfactant reduces pulmonary injury in rat ischaemia/reperfusion." European Respiratory Journal 33.3 (2009): 625-633. Web. 11 May. 2021.

  8. Been, J. V.

    1. Been, J. V. et al "A 3-year-old female with cough, dyspnoea and low-grade fever." European Respiratory Journal 33.3 (2009): 690-693. Web. 11 May. 2021.

  9. Bein, T.

    1. Müller, T. et al "Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy." European Respiratory Journal 33.3 (2009): 551-558. Web. 11 May. 2021.

  10. Benitez, P.

    1. Pujols, L. et al "Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo." European Respiratory Journal 33.3 (2009): 502-508. Web. 11 May. 2021.

  11. Benjamin, A.

    1. Champagne, K. et al "Obstructive sleep apnoea and its association with gestational hypertension." European Respiratory Journal 33.3 (2009): 559-565. Web. 11 May. 2021.

  12. Benucci, M.

    1. Bartalesi, F. et al "QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases." European Respiratory Journal 33.3 (2009): 586-593. Web. 11 May. 2021.

  13. Birnbaum, D.

    1. Müller, T. et al "Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy." European Respiratory Journal 33.3 (2009): 551-558. Web. 11 May. 2021.

  14. Birukov, K. G.

    1. Fu, P. et al "Amifostine reduces lung vascular permeability via suppression of inflammatory signalling." European Respiratory Journal 33.3 (2009): 612-624. Web. 11 May. 2021.

  15. Birukova, A. A.

    1. Fu, P. et al "Amifostine reduces lung vascular permeability via suppression of inflammatory signalling." European Respiratory Journal 33.3 (2009): 612-624. Web. 11 May. 2021.

  16. Bosch, A.

    1. Mühlfeld, C. et al "Pre-ischaemic exogenous surfactant reduces pulmonary injury in rat ischaemia/reperfusion." European Respiratory Journal 33.3 (2009): 625-633. Web. 11 May. 2021.

  17. Bourbeau, J.

    1. Bourbeau, J., and J. van der Palen. "Promoting effective self-management programmes to improve COPD." European Respiratory Journal 33.3 (2009): 461-463. Web. 11 May. 2021.

  18. Bouros, D.

    1. Bouros, D., and G. Giannakoulas. " From the authors ." European Respiratory Journal 33.3 (2009): 703-704. Web. 11 May. 2021.

  19. Boutet, K.

    1. Boutet, K. et al "Fenfluramine-like cardiovascular side-effects of benfluorex." European Respiratory Journal 33.3 (2009): 684-688. Web. 11 May. 2021.

  20. Bozza, P. T.

    1. Silva, P. L. et al "Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury." European Respiratory Journal 33.3 (2009): 634-645. Web. 11 May. 2021.

  21. Brand, P. L. P.

    1. Brand, P. L. P., and A. Bush. " From the authors ." European Respiratory Journal 33.3 (2009): 707-708. Web. 11 May. 2021.

  22. Britton, J. R.

    1. Fogarty, A. W. et al "A natural experiment on the impact of fruit supplementation on asthma symptoms in children." European Respiratory Journal 33.3 (2009): 481-485. Web. 11 May. 2021.

  23. Bush, A.

    1. Gappa, M. et al "Paediatric HERMES: update of the European Training Syllabus for Paediatric Respiratory Medicine." European Respiratory Journal 33.3 (2009): 464-465. Web. 11 May. 2021.
    2. Bush, A. et al " To the Editors ." European Respiratory Journal 33.3 (2009): 705-706. Web. 11 May. 2021.
    3. Brand, P. L. P., and A. Bush. " From the authors ." European Respiratory Journal 33.3 (2009): 707-708. Web. 11 May. 2021.

  24. Bussinger, C.

    1. Mühlfeld, C. et al "Pre-ischaemic exogenous surfactant reduces pulmonary injury in rat ischaemia/reperfusion." European Respiratory Journal 33.3 (2009): 625-633. Web. 11 May. 2021.

C

  1. Cagido, V. R.

    1. Silva, P. L. et al "Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury." European Respiratory Journal 33.3 (2009): 634-645. Web. 11 May. 2021.

  2. Calverley, P. M. A.

    1. Keene, O. N. et al "Lung function decline in COPD trials." European Respiratory Journal 33.3 (2009): 708-709. Web. 11 May. 2021.

  3. Capelozzi, V. L.

    1. Silva, P. L. et al "Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury." European Respiratory Journal 33.3 (2009): 634-645. Web. 11 May. 2021.

  4. Carlhant-Kowalski, D.

    1. Boutet, K. et al "Fenfluramine-like cardiovascular side-effects of benfluorex." European Respiratory Journal 33.3 (2009): 684-688. Web. 11 May. 2021.

  5. Carlsen, K-H.

    1. Gappa, M. et al "Paediatric HERMES: update of the European Training Syllabus for Paediatric Respiratory Medicine." European Respiratory Journal 33.3 (2009): 464-465. Web. 11 May. 2021.

  6. Casanova, C.

    1. de Torres, J. P. et al "Sex differences in mortality in patients with COPD." European Respiratory Journal 33.3 (2009): 528-535. Web. 11 May. 2021.

  7. Celli, B.

    1. Keene, O. N. et al "Lung function decline in COPD trials." European Respiratory Journal 33.3 (2009): 708-709. Web. 11 May. 2021.

  8. Celli, B. R.

    1. de Torres, J. P. et al "Sex differences in mortality in patients with COPD." European Respiratory Journal 33.3 (2009): 528-535. Web. 11 May. 2021.

  9. Cerinic, M. M.

    1. Bartalesi, F. et al "QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases." European Respiratory Journal 33.3 (2009): 586-593. Web. 11 May. 2021.

  10. Challis, D.

    1. Dwyer, N. et al "Granulomatous angiitis leading to a pulmonary veno-occlusive disease-like picture." European Respiratory Journal 33.3 (2009): 666-669. Web. 11 May. 2021.

  11. Champagne, K.

    1. Champagne, K. et al "Obstructive sleep apnoea and its association with gestational hypertension." European Respiratory Journal 33.3 (2009): 559-565. Web. 11 May. 2021.

  12. Chang, A. B.

    1. Weir, K. et al "Clinical signs and symptoms of oropharyngeal aspiration and dysphagia in children." European Respiratory Journal 33.3 (2009): 604-611. Web. 11 May. 2021.

  13. Chatwin, M.

    1. Jaye, J. et al "Autotitrating versus standard noninvasive ventilation: a randomised crossover trial." European Respiratory Journal 33.3 (2009): 566-571. Web. 11 May. 2021.

  14. Chen, B.

    1. Zhou, Y. et al "COPD in Chinese nonsmokers." European Respiratory Journal 33.3 (2009): 509-518. Web. 11 May. 2021.

  15. Chen, F.

    1. Sheu, C. C. et al "Sex-specific association of epidermal growth factor gene polymorphisms with acute respiratory distress syndrome." European Respiratory Journal 33.3 (2009): 543-550. Web. 11 May. 2021.

  16. Chen, P.

    1. Zhou, Y. et al "COPD in Chinese nonsmokers." European Respiratory Journal 33.3 (2009): 509-518. Web. 11 May. 2021.

  17. Christiani, D. C.

    1. Sheu, C. C. et al "Sex-specific association of epidermal growth factor gene polymorphisms with acute respiratory distress syndrome." European Respiratory Journal 33.3 (2009): 543-550. Web. 11 May. 2021.

  18. Connell, M.

    1. Mair, G. et al "Computed tomographic emphysema distribution: relationship to clinical features in a cohort of smokers." European Respiratory Journal 33.3 (2009): 536-542. Web. 11 May. 2021.

  19. Cote, C. G.

    1. de Torres, J. P. et al "Sex differences in mortality in patients with COPD." European Respiratory Journal 33.3 (2009): 528-535. Web. 11 May. 2021.

  20. Craig, S.

    1. Ayers, L. et al "Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea." European Respiratory Journal 33.3 (2009): 574-580. Web. 11 May. 2021.

D

  1. Damaceno-Rodrigues, N. R.

    1. Silva, P. L. et al "Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury." European Respiratory Journal 33.3 (2009): 634-645. Web. 11 May. 2021.

  2. Daniels, J. M. A.

    1. Daniels, J. M. A. et al "Tuberculosis complicating imatinib treatment for chronic myeloid leukaemia." European Respiratory Journal 33.3 (2009): 670-672. Web. 11 May. 2021.

  3. Davies, L.

    1. Fogarty, A. W. et al "A natural experiment on the impact of fruit supplementation on asthma symptoms in children." European Respiratory Journal 33.3 (2009): 481-485. Web. 11 May. 2021.

  4. Dayer, M.

    1. Jaye, J. et al "Autotitrating versus standard noninvasive ventilation: a randomised crossover trial." European Respiratory Journal 33.3 (2009): 566-571. Web. 11 May. 2021.

  5. de Benedictis, F. M.

    1. Bush, A. et al " To the Editors ." European Respiratory Journal 33.3 (2009): 705-706. Web. 11 May. 2021.

  6. de Castellar, R.

    1. Miravitlles, M. et al "Validation of the COPD severity score for use in primary care: the NEREA study." European Respiratory Journal 33.3 (2009): 519-527. Web. 11 May. 2021.

  7. de Jongste, J. C.

    1. Gappa, M. et al "Paediatric HERMES: update of the European Training Syllabus for Paediatric Respiratory Medicine." European Respiratory Journal 33.3 (2009): 464-465. Web. 11 May. 2021.

  8. Delhaas, T.

    1. Been, J. V. et al "A 3-year-old female with cough, dyspnoea and low-grade fever." European Respiratory Journal 33.3 (2009): 690-693. Web. 11 May. 2021.

  9. de Oca, M. M.

    1. de Torres, J. P. et al "Sex differences in mortality in patients with COPD." European Respiratory Journal 33.3 (2009): 528-535. Web. 11 May. 2021.

  10. de Torres, J. P.

    1. de Torres, J. P. et al "Sex differences in mortality in patients with COPD." European Respiratory Journal 33.3 (2009): 528-535. Web. 11 May. 2021.

  11. Díaz, O.

    1. de Torres, J. P. et al "Sex differences in mortality in patients with COPD." European Respiratory Journal 33.3 (2009): 528-535. Web. 11 May. 2021.

  12. Diefenbach, K.

    1. Riha, R. L., T. Gislasson, and K. Diefenbach. "The phenotype and genotype of adult obstructive sleep apnoea/hypopnoea syndrome." European Respiratory Journal 33.3 (2009): 646-655. Web. 11 May. 2021.

  13. Doekes, G.

    1. Pronk, A. et al "Different respiratory phenotypes are associated with isocyanate exposure in spray painters." European Respiratory Journal 33.3 (2009): 494-501. Web. 11 May. 2021.

  14. Dompeling, E.

    1. Been, J. V. et al "A 3-year-old female with cough, dyspnoea and low-grade fever." European Respiratory Journal 33.3 (2009): 690-693. Web. 11 May. 2021.

  15. Donado, E.

    1. Miravitlles, M. et al "Validation of the COPD severity score for use in primary care: the NEREA study." European Respiratory Journal 33.3 (2009): 519-527. Web. 11 May. 2021.

  16. Dordelly, L. J.

    1. de Torres, J. P. et al "Sex differences in mortality in patients with COPD." European Respiratory Journal 33.3 (2009): 528-535. Web. 11 May. 2021.

  17. Dwyer, N.

    1. Dwyer, N. et al "Granulomatous angiitis leading to a pulmonary veno-occlusive disease-like picture." European Respiratory Journal 33.3 (2009): 666-669. Web. 11 May. 2021.

E

  1. Eber, E.

    1. Gappa, M. et al "Paediatric HERMES: update of the European Training Syllabus for Paediatric Respiratory Medicine." European Respiratory Journal 33.3 (2009): 464-465. Web. 11 May. 2021.

F

  1. Fauroux, B.

    1. Gappa, M. et al "Paediatric HERMES: update of the European Training Syllabus for Paediatric Respiratory Medicine." European Respiratory Journal 33.3 (2009): 464-465. Web. 11 May. 2021.

  2. Ferguson, G. T.

    1. Keene, O. N. et al "Lung function decline in COPD trials." European Respiratory Journal 33.3 (2009): 708-709. Web. 11 May. 2021.

  3. Ferry, B.

    1. Ayers, L. et al "Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea." European Respiratory Journal 33.3 (2009): 574-580. Web. 11 May. 2021.

  4. Fiorelli, C.

    1. Bartalesi, F. et al "QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases." European Respiratory Journal 33.3 (2009): 586-593. Web. 11 May. 2021.

  5. Fiori, G.

    1. Bartalesi, F. et al "QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases." European Respiratory Journal 33.3 (2009): 586-593. Web. 11 May. 2021.

  6. Fogarty, A. W.

    1. Fogarty, A. W. et al "A natural experiment on the impact of fruit supplementation on asthma symptoms in children." European Respiratory Journal 33.3 (2009): 481-485. Web. 11 May. 2021.

  7. Frachon, I.

    1. Boutet, K. et al "Fenfluramine-like cardiovascular side-effects of benfluorex." European Respiratory Journal 33.3 (2009): 684-688. Web. 11 May. 2021.

  8. Frey, U.

    1. Latzin, P. et al "Air pollution during pregnancy and lung function in newborns: a birth cohort study." European Respiratory Journal 33.3 (2009): 594-603. Web. 11 May. 2021.
    2. Thamrin, C. et al "Fluctuation analysis of lung function as a predictor of long-term response to β2-agonists." European Respiratory Journal 33.3 (2009): 486-493. Web. 11 May. 2021.

  9. Fu, P.

    1. Fu, P. et al "Amifostine reduces lung vascular permeability via suppression of inflammatory signalling." European Respiratory Journal 33.3 (2009): 612-624. Web. 11 May. 2021.

G

  1. Gappa, M.

    1. Gappa, M. et al "Paediatric HERMES: update of the European Training Syllabus for Paediatric Respiratory Medicine." European Respiratory Journal 33.3 (2009): 464-465. Web. 11 May. 2021.

  2. Garcia, C. S. N. B.

    1. Silva, P. L. et al "Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury." European Respiratory Journal 33.3 (2009): 634-645. Web. 11 May. 2021.

  3. Garcia, J. G. N.

    1. Fu, P. et al "Amifostine reduces lung vascular permeability via suppression of inflammatory signalling." European Respiratory Journal 33.3 (2009): 612-624. Web. 11 May. 2021.

  4. Giannakoulas, G.

    1. Bouros, D., and G. Giannakoulas. " From the authors ." European Respiratory Journal 33.3 (2009): 703-704. Web. 11 May. 2021.

  5. Girardi, E.

    1. Bartalesi, F. et al "QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases." European Respiratory Journal 33.3 (2009): 586-593. Web. 11 May. 2021.

  6. Gislasson, T.

    1. Riha, R. L., T. Gislasson, and K. Diefenbach. "The phenotype and genotype of adult obstructive sleep apnoea/hypopnoea syndrome." European Respiratory Journal 33.3 (2009): 646-655. Web. 11 May. 2021.

  7. Goletti, D.

    1. Bartalesi, F. et al "QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases." European Respiratory Journal 33.3 (2009): 586-593. Web. 11 May. 2021.

  8. Gong, M. N.

    1. Sheu, C. C. et al "Sex-specific association of epidermal growth factor gene polymorphisms with acute respiratory distress syndrome." European Respiratory Journal 33.3 (2009): 543-550. Web. 11 May. 2021.

  9. Goodwin, A.

    1. Fogarty, A. W. et al "A natural experiment on the impact of fruit supplementation on asthma symptoms in children." European Respiratory Journal 33.3 (2009): 481-485. Web. 11 May. 2021.

  10. Grdina, D. J.

    1. Fu, P. et al "Amifostine reduces lung vascular permeability via suppression of inflammatory signalling." European Respiratory Journal 33.3 (2009): 612-624. Web. 11 May. 2021.

  11. Gut-Gobert, C.

    1. Boutet, K. et al "Fenfluramine-like cardiovascular side-effects of benfluorex." European Respiratory Journal 33.3 (2009): 684-688. Web. 11 May. 2021.

H

  1. Hamano, H.

    1. Ito, M. et al "Central airway stenosis in a patient with autoimmune pancreatitis." European Respiratory Journal 33.3 (2009): 680-683. Web. 11 May. 2021.

  2. Han, S. K.

    1. Hwang, S. S. et al "Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB." European Respiratory Journal 33.3 (2009): 581-585. Web. 11 May. 2021.

  3. Hedlin, G.

    1. Bush, A. et al " To the Editors ." European Respiratory Journal 33.3 (2009): 705-706. Web. 11 May. 2021.

  4. Heederik, D.

    1. Pronk, A. et al "Different respiratory phenotypes are associated with isocyanate exposure in spray painters." European Respiratory Journal 33.3 (2009): 494-501. Web. 11 May. 2021.

  5. Honda, T.

    1. Ito, M. et al "Central airway stenosis in a patient with autoimmune pancreatitis." European Respiratory Journal 33.3 (2009): 680-683. Web. 11 May. 2021.

  6. Howard, P.

    1. Howard, P.. "In memoriam Wendy Thompson, 1944–2008." European Respiratory Journal 33.3 (2009): 457-458. Web. 11 May. 2021.

  7. Huang, S.

    1. Zhou, Y. et al "COPD in Chinese nonsmokers." European Respiratory Journal 33.3 (2009): 509-518. Web. 11 May. 2021.

  8. Humbert, M.

    1. Humbert, M.. "Introducing the new European Respiratory Review." European Respiratory Journal 33.3 (2009): 466-467. Web. 11 May. 2021.
    2. Boutet, K. et al "Fenfluramine-like cardiovascular side-effects of benfluorex." European Respiratory Journal 33.3 (2009): 684-688. Web. 11 May. 2021.

  9. Huss, A.

    1. Latzin, P. et al "Air pollution during pregnancy and lung function in newborns: a birth cohort study." European Respiratory Journal 33.3 (2009): 594-603. Web. 11 May. 2021.

  10. Hwang, S. S.

    1. Hwang, S. S. et al "Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB." European Respiratory Journal 33.3 (2009): 581-585. Web. 11 May. 2021.

I

  1. Ito, M.

    1. Ito, M. et al "Central airway stenosis in a patient with autoimmune pancreatitis." European Respiratory Journal 33.3 (2009): 680-683. Web. 11 May. 2021.

  2. Izquierdo, I.

    1. Miravitlles, M. et al "Validation of the COPD severity score for use in primary care: the NEREA study." European Respiratory Journal 33.3 (2009): 519-527. Web. 11 May. 2021.

J

  1. Janssen, J. J. W. M.

    1. Daniels, J. M. A. et al "Tuberculosis complicating imatinib treatment for chronic myeloid leukaemia." European Respiratory Journal 33.3 (2009): 670-672. Web. 11 May. 2021.

  2. Jartti, T.

    1. Jartti, T., M. Korppi, and O. Ruuskanen. "The clinical importance of rhinovirus-associated early wheezing." European Respiratory Journal 33.3 (2009): 706-707. Web. 11 May. 2021.

  3. Jastrzebski, D.

    1. Jastrzebski, D. et al "Left ventricular dysfunction in patients with interstitial lung diseases." European Respiratory Journal 33.3 (2009): 702-703. Web. 11 May. 2021.

  4. Jaye, J.

    1. Jaye, J. et al "Autotitrating versus standard noninvasive ventilation: a randomised crossover trial." European Respiratory Journal 33.3 (2009): 566-571. Web. 11 May. 2021.

  5. Jenkins, C. R.

    1. Keene, O. N. et al "Lung function decline in COPD trials." European Respiratory Journal 33.3 (2009): 708-709. Web. 11 May. 2021.

  6. Jeron, A.

    1. Müller, T. et al "Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy." European Respiratory Journal 33.3 (2009): 551-558. Web. 11 May. 2021.

  7. Jobic, Y.

    1. Boutet, K. et al "Fenfluramine-like cardiovascular side-effects of benfluorex." European Respiratory Journal 33.3 (2009): 684-688. Web. 11 May. 2021.

  8. Jöbsis, Q.

    1. Been, J. V. et al "A 3-year-old female with cough, dyspnoea and low-grade fever." European Respiratory Journal 33.3 (2009): 690-693. Web. 11 May. 2021.

  9. Jones, P. W.

    1. Keene, O. N. et al "Lung function decline in COPD trials." European Respiratory Journal 33.3 (2009): 708-709. Web. 11 May. 2021.

K

  1. Kang, J.

    1. Zhou, Y. et al "COPD in Chinese nonsmokers." European Respiratory Journal 33.3 (2009): 509-518. Web. 11 May. 2021.

  2. Kawa, S.

    1. Ito, M. et al "Central airway stenosis in a patient with autoimmune pancreatitis." European Respiratory Journal 33.3 (2009): 680-683. Web. 11 May. 2021.

  3. Kawakami, S.

    1. Ito, M. et al "Central airway stenosis in a patient with autoimmune pancreatitis." European Respiratory Journal 33.3 (2009): 680-683. Web. 11 May. 2021.

  4. Keene, O. N.

    1. Keene, O. N. et al "Lung function decline in COPD trials." European Respiratory Journal 33.3 (2009): 708-709. Web. 11 May. 2021.

  5. Kilpatrick, D.

    1. Dwyer, N. et al "Granulomatous angiitis leading to a pulmonary veno-occlusive disease-like picture." European Respiratory Journal 33.3 (2009): 666-669. Web. 11 May. 2021.

  6. Kim, H-R.

    1. Hwang, S. S. et al "Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB." European Respiratory Journal 33.3 (2009): 581-585. Web. 11 May. 2021.

  7. Kim, H. J.

    1. Hwang, S. S. et al "Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB." European Respiratory Journal 33.3 (2009): 581-585. Web. 11 May. 2021.

  8. Kim, M. J.

    1. Hwang, S. S. et al "Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB." European Respiratory Journal 33.3 (2009): 581-585. Web. 11 May. 2021.

  9. Kim, Y. W.

    1. Hwang, S. S. et al "Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB." European Respiratory Journal 33.3 (2009): 581-585. Web. 11 May. 2021.

  10. Kimoff, R. J.

    1. Champagne, K. et al "Obstructive sleep apnoea and its association with gestational hypertension." European Respiratory Journal 33.3 (2009): 559-565. Web. 11 May. 2021.

  11. Knaapen, A. M.

    1. Quaak, M. et al "Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases?." European Respiratory Journal 33.3 (2009): 468-480. Web. 11 May. 2021.

  12. Knobil, K.

    1. Keene, O. N. et al "Lung function decline in COPD trials." European Respiratory Journal 33.3 (2009): 708-709. Web. 11 May. 2021.

  13. Kohler, M.

    1. Ayers, L. et al "Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea." European Respiratory Journal 33.3 (2009): 574-580. Web. 11 May. 2021.

  14. Korppi, M.

    1. Jartti, T., M. Korppi, and O. Ruuskanen. "The clinical importance of rhinovirus-associated early wheezing." European Respiratory Journal 33.3 (2009): 706-707. Web. 11 May. 2021.

  15. Kozielski, J.

    1. Jastrzebski, D. et al "Left ventricular dysfunction in patients with interstitial lung diseases." European Respiratory Journal 33.3 (2009): 702-703. Web. 11 May. 2021.

  16. Kubo, K.

    1. Ito, M. et al "Central airway stenosis in a patient with autoimmune pancreatitis." European Respiratory Journal 33.3 (2009): 680-683. Web. 11 May. 2021.

  17. Kuehni, C. E.

    1. Latzin, P. et al "Air pollution during pregnancy and lung function in newborns: a birth cohort study." European Respiratory Journal 33.3 (2009): 594-603. Web. 11 May. 2021.
    2. Thamrin, C. et al "Fluctuation analysis of lung function as a predictor of long-term response to β2-agonists." European Respiratory Journal 33.3 (2009): 486-493. Web. 11 May. 2021.

  18. Kurukulaaratchy, R. J.

    1. Scott, M. et al "Understanding the nature and outcome of childhood wheezing." European Respiratory Journal 33.3 (2009): 700-701. Web. 11 May. 2021.

L

  1. Lam, B.

    1. McWilliams, A., B. Lam, and T. Sutedja. "Early proximal lung cancer diagnosis and treatment." European Respiratory Journal 33.3 (2009): 656-665. Web. 11 May. 2021.

  2. Lammers, J-W.

    1. Pronk, A. et al "Different respiratory phenotypes are associated with isocyanate exposure in spray painters." European Respiratory Journal 33.3 (2009): 494-501. Web. 11 May. 2021.

  3. Langgartner, J.

    1. Müller, T. et al "Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy." European Respiratory Journal 33.3 (2009): 551-558. Web. 11 May. 2021.

  4. Latzin, P.

    1. Latzin, P. et al "Air pollution during pregnancy and lung function in newborns: a birth cohort study." European Respiratory Journal 33.3 (2009): 594-603. Web. 11 May. 2021.

  5. Lee, S. M.

    1. Hwang, S. S. et al "Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB." European Respiratory Journal 33.3 (2009): 581-585. Web. 11 May. 2021.

  6. Lerman, Y.

    1. Mor, Z., Y. Lerman, and A. Leventhal. "Pre-immigration screening for pulmonary tuberculosis." European Respiratory Journal 33.3 (2009): 701-702. Web. 11 May. 2021.

  7. Leroyer, C.

    1. Boutet, K. et al "Fenfluramine-like cardiovascular side-effects of benfluorex." European Respiratory Journal 33.3 (2009): 684-688. Web. 11 May. 2021.

  8. Leventhal, A.

    1. Mor, Z., Y. Lerman, and A. Leventhal. "Pre-immigration screening for pulmonary tuberculosis." European Respiratory Journal 33.3 (2009): 701-702. Web. 11 May. 2021.

  9. Lewis, S. A.

    1. Fogarty, A. W. et al "A natural experiment on the impact of fruit supplementation on asthma symptoms in children." European Respiratory Journal 33.3 (2009): 481-485. Web. 11 May. 2021.

  10. Liu, S.

    1. Zhou, Y. et al "COPD in Chinese nonsmokers." European Respiratory Journal 33.3 (2009): 509-518. Web. 11 May. 2021.

  11. Llor, C.

    1. Miravitlles, M. et al "Validation of the COPD severity score for use in primary care: the NEREA study." European Respiratory Journal 33.3 (2009): 519-527. Web. 11 May. 2021.

  12. López, M. V.

    1. de Torres, J. P. et al "Sex differences in mortality in patients with COPD." European Respiratory Journal 33.3 (2009): 528-535. Web. 11 May. 2021.

  13. Lu, J.

    1. Zhou, Y. et al "COPD in Chinese nonsmokers." European Respiratory Journal 33.3 (2009): 509-518. Web. 11 May. 2021.

  14. Lubnow, M.

    1. Müller, T. et al "Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy." European Respiratory Journal 33.3 (2009): 551-558. Web. 11 May. 2021.

  15. Luchner, A.

    1. Müller, T. et al "Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy." European Respiratory Journal 33.3 (2009): 551-558. Web. 11 May. 2021.

  16. Lumsden, D. E.

    1. Lumsden, D. E. et al "Pulmonary mass in an infant." European Respiratory Journal 33.3 (2009): 694-699. Web. 11 May. 2021.

M

  1. Maclay, J.

    1. Mair, G. et al "Computed tomographic emphysema distribution: relationship to clinical features in a cohort of smokers." European Respiratory Journal 33.3 (2009): 536-542. Web. 11 May. 2021.

  2. MacNee, W.

    1. Mair, G. et al "Computed tomographic emphysema distribution: relationship to clinical features in a cohort of smokers." European Respiratory Journal 33.3 (2009): 536-542. Web. 11 May. 2021.

  3. Madershahian, N.

    1. Mühlfeld, C. et al "Pre-ischaemic exogenous surfactant reduces pulmonary injury in rat ischaemia/reperfusion." European Respiratory Journal 33.3 (2009): 625-633. Web. 11 May. 2021.

  4. Madsen, F.

    1. Madsen, F.. "A new perspective on concepts of asthma severity, control and optimum treatment." European Respiratory Journal 33.3 (2009): 704-705. Web. 11 May. 2021.

  5. Mair, G.

    1. Mair, G. et al "Computed tomographic emphysema distribution: relationship to clinical features in a cohort of smokers." European Respiratory Journal 33.3 (2009): 536-542. Web. 11 May. 2021.

  6. Mallozzi, A.

    1. Champagne, K. et al "Obstructive sleep apnoea and its association with gestational hypertension." European Respiratory Journal 33.3 (2009): 559-565. Web. 11 May. 2021.

  7. Mantella, A.

    1. Bartalesi, F. et al "QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases." European Respiratory Journal 33.3 (2009): 586-593. Web. 11 May. 2021.

  8. Mapp, C. E.

    1. Mapp, C. E.. "What is the role of genetics in occupational asthma?." European Respiratory Journal 33.3 (2009): 459-460. Web. 11 May. 2021.

  9. Marin, J. M.

    1. de Torres, J. P. et al "Sex differences in mortality in patients with COPD." European Respiratory Journal 33.3 (2009): 528-535. Web. 11 May. 2021.

  10. Maronas, P. A.

    1. Silva, P. L. et al "Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury." European Respiratory Journal 33.3 (2009): 634-645. Web. 11 May. 2021.

  11. Martinez-Antón, A.

    1. Pujols, L. et al "Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo." European Respiratory Journal 33.3 (2009): 502-508. Web. 11 May. 2021.

  12. Masters, I. B.

    1. Weir, K. et al "Clinical signs and symptoms of oropharyngeal aspiration and dysphagia in children." European Respiratory Journal 33.3 (2009): 604-611. Web. 11 May. 2021.

  13. McAllister, D.

    1. Mair, G. et al "Computed tomographic emphysema distribution: relationship to clinical features in a cohort of smokers." European Respiratory Journal 33.3 (2009): 536-542. Web. 11 May. 2021.

  14. McKenzie, S.

    1. Gappa, M. et al "Paediatric HERMES: update of the European Training Syllabus for Paediatric Respiratory Medicine." European Respiratory Journal 33.3 (2009): 464-465. Web. 11 May. 2021.

  15. McMahon, S.

    1. Weir, K. et al "Clinical signs and symptoms of oropharyngeal aspiration and dysphagia in children." European Respiratory Journal 33.3 (2009): 604-611. Web. 11 May. 2021.

  16. McWilliams, A.

    1. McWilliams, A., B. Lam, and T. Sutedja. "Early proximal lung cancer diagnosis and treatment." European Respiratory Journal 33.3 (2009): 656-665. Web. 11 May. 2021.

  17. Melchiorre, D.

    1. Bartalesi, F. et al "QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases." European Respiratory Journal 33.3 (2009): 586-593. Web. 11 May. 2021.

  18. Miller, J. J.

    1. Mair, G. et al "Computed tomographic emphysema distribution: relationship to clinical features in a cohort of smokers." European Respiratory Journal 33.3 (2009): 536-542. Web. 11 May. 2021.

  19. Miravitlles, M.

    1. Miravitlles, M. et al "Validation of the COPD severity score for use in primary care: the NEREA study." European Respiratory Journal 33.3 (2009): 519-527. Web. 11 May. 2021.

  20. Mor, Z.

    1. Mor, Z., Y. Lerman, and A. Leventhal. "Pre-immigration screening for pulmonary tuberculosis." European Respiratory Journal 33.3 (2009): 701-702. Web. 11 May. 2021.

  21. Morin, L.

    1. Champagne, K. et al "Obstructive sleep apnoea and its association with gestational hypertension." European Respiratory Journal 33.3 (2009): 559-565. Web. 11 May. 2021.

  22. Morrell, M. J.

    1. Jaye, J. et al "Autotitrating versus standard noninvasive ventilation: a randomised crossover trial." European Respiratory Journal 33.3 (2009): 566-571. Web. 11 May. 2021.

  23. Mühlfeld, C.

    1. Mühlfeld, C. et al "Pre-ischaemic exogenous surfactant reduces pulmonary injury in rat ischaemia/reperfusion." European Respiratory Journal 33.3 (2009): 625-633. Web. 11 May. 2021.

  24. Müller, T.

    1. Müller, T. et al "Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy." European Respiratory Journal 33.3 (2009): 551-558. Web. 11 May. 2021.

  25. Mullol, J.

    1. Pujols, L. et al "Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo." European Respiratory Journal 33.3 (2009): 502-508. Web. 11 May. 2021.

  26. Murchison, J. T.

    1. Mair, G. et al "Computed tomographic emphysema distribution: relationship to clinical features in a cohort of smokers." European Respiratory Journal 33.3 (2009): 536-542. Web. 11 May. 2021.

  27. Murley, J. S.

    1. Fu, P. et al "Amifostine reduces lung vascular permeability via suppression of inflammatory signalling." European Respiratory Journal 33.3 (2009): 612-624. Web. 11 May. 2021.

N

  1. Nagib, R.

    1. Mühlfeld, C. et al "Pre-ischaemic exogenous surfactant reduces pulmonary injury in rat ischaemia/reperfusion." European Respiratory Journal 33.3 (2009): 625-633. Web. 11 May. 2021.

  2. Negri, E. M.

    1. Silva, P. L. et al "Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury." European Respiratory Journal 33.3 (2009): 634-645. Web. 11 May. 2021.

  3. Nekach, H.

    1. de Torres, J. P. et al "Sex differences in mortality in patients with COPD." European Respiratory Journal 33.3 (2009): 528-535. Web. 11 May. 2021.

  4. Ni, D.

    1. Zhou, Y. et al "COPD in Chinese nonsmokers." European Respiratory Journal 33.3 (2009): 509-518. Web. 11 May. 2021.

  5. Nicoll, D.

    1. Ayers, L. et al "Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea." European Respiratory Journal 33.3 (2009): 574-580. Web. 11 May. 2021.

  6. Noël, J-L.

    1. Gappa, M. et al "Paediatric HERMES: update of the European Training Syllabus for Paediatric Respiratory Medicine." European Respiratory Journal 33.3 (2009): 464-465. Web. 11 May. 2021.

  7. Nowak, J.

    1. Jastrzebski, D. et al "Left ventricular dysfunction in patients with interstitial lung diseases." European Respiratory Journal 33.3 (2009): 702-703. Web. 11 May. 2021.

O

  1. Ochs, M.

    1. Mühlfeld, C. et al "Pre-ischaemic exogenous surfactant reduces pulmonary injury in rat ischaemia/reperfusion." European Respiratory Journal 33.3 (2009): 625-633. Web. 11 May. 2021.

  2. Olsen, O.

    1. Lumsden, D. E. et al "Pulmonary mass in an infant." European Respiratory Journal 33.3 (2009): 694-699. Web. 11 May. 2021.

  3. Opatrny, L.

    1. Champagne, K. et al "Obstructive sleep apnoea and its association with gestational hypertension." European Respiratory Journal 33.3 (2009): 559-565. Web. 11 May. 2021.

P

  1. Palange, P.

    1. Gappa, M. et al "Paediatric HERMES: update of the European Training Syllabus for Paediatric Respiratory Medicine." European Respiratory Journal 33.3 (2009): 464-465. Web. 11 May. 2021.

  2. Paton, J.

    1. Gappa, M. et al "Paediatric HERMES: update of the European Training Syllabus for Paediatric Respiratory Medicine." European Respiratory Journal 33.3 (2009): 464-465. Web. 11 May. 2021.

  3. Paton, J. Y.

    1. Bush, A. et al " To the Editors ." European Respiratory Journal 33.3 (2009): 705-706. Web. 11 May. 2021.

  4. Pelosi, P.

    1. Silva, P. L. et al "Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury." European Respiratory Journal 33.3 (2009): 634-645. Web. 11 May. 2021.

  5. Persson, H. L.

    1. Persson, H. L., and L. K. Vainikka. "Lysosomal iron in pulmonary alveolar proteinosis: a case report." European Respiratory Journal 33.3 (2009): 673-679. Web. 11 May. 2021.

  6. Pfeifer, M.

    1. Müller, T. et al "Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy." European Respiratory Journal 33.3 (2009): 551-558. Web. 11 May. 2021.

  7. Philipp, A.

    1. Müller, T. et al "Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy." European Respiratory Journal 33.3 (2009): 551-558. Web. 11 May. 2021.

  8. Picado, C.

    1. Pujols, L. et al "Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo." European Respiratory Journal 33.3 (2009): 502-508. Web. 11 May. 2021.

  9. Pinto-Plata, V.

    1. de Torres, J. P. et al "Sex differences in mortality in patients with COPD." European Respiratory Journal 33.3 (2009): 528-535. Web. 11 May. 2021.

  10. Pohunek, P.

    1. Gappa, M. et al "Paediatric HERMES: update of the European Training Syllabus for Paediatric Respiratory Medicine." European Respiratory Journal 33.3 (2009): 464-465. Web. 11 May. 2021.

  11. Polonski, L.

    1. Jastrzebski, D. et al "Left ventricular dysfunction in patients with interstitial lung diseases." European Respiratory Journal 33.3 (2009): 702-703. Web. 11 May. 2021.

  12. Postmus, P. E.

    1. Daniels, J. M. A. et al "Tuberculosis complicating imatinib treatment for chronic myeloid leukaemia." European Respiratory Journal 33.3 (2009): 670-672. Web. 11 May. 2021.

  13. Preller, L.

    1. Pronk, A. et al "Different respiratory phenotypes are associated with isocyanate exposure in spray painters." European Respiratory Journal 33.3 (2009): 494-501. Web. 11 May. 2021.

  14. Priftis, K.

    1. Gappa, M. et al "Paediatric HERMES: update of the European Training Syllabus for Paediatric Respiratory Medicine." European Respiratory Journal 33.3 (2009): 464-465. Web. 11 May. 2021.

  15. Pronk, A.

    1. Pronk, A. et al "Different respiratory phenotypes are associated with isocyanate exposure in spray painters." European Respiratory Journal 33.3 (2009): 494-501. Web. 11 May. 2021.

  16. Pujols, L.

    1. Pujols, L. et al "Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo." European Respiratory Journal 33.3 (2009): 502-508. Web. 11 May. 2021.

Q

  1. Quaak, M.

    1. Quaak, M. et al "Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases?." European Respiratory Journal 33.3 (2009): 468-480. Web. 11 May. 2021.

R

  1. Ran, P.

    1. Zhou, Y. et al "COPD in Chinese nonsmokers." European Respiratory Journal 33.3 (2009): 509-518. Web. 11 May. 2021.

  2. Raza, A.

    1. Scott, M. et al "Understanding the nature and outcome of childhood wheezing." European Respiratory Journal 33.3 (2009): 700-701. Web. 11 May. 2021.

  3. Reddel, H. K.

    1. Taylor, D. R., and H. K. Reddel. " From the authors ." European Respiratory Journal 33.3 (2009): 706. Web. 11 May. 2021.

  4. Reid, D.

    1. Dwyer, N. et al "Granulomatous angiitis leading to a pulmonary veno-occlusive disease-like picture." European Respiratory Journal 33.3 (2009): 666-669. Web. 11 May. 2021.

  5. Reng, M.

    1. Müller, T. et al "Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy." European Respiratory Journal 33.3 (2009): 551-558. Web. 11 May. 2021.

  6. Richter, J.

    1. Mühlfeld, C. et al "Pre-ischaemic exogenous surfactant reduces pulmonary injury in rat ischaemia/reperfusion." European Respiratory Journal 33.3 (2009): 625-633. Web. 11 May. 2021.

  7. Riegger, G. A. J.

    1. Müller, T. et al "Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy." European Respiratory Journal 33.3 (2009): 551-558. Web. 11 May. 2021.

  8. Riha, R. L.

    1. Riha, R. L., T. Gislasson, and K. Diefenbach. "The phenotype and genotype of adult obstructive sleep apnoea/hypopnoea syndrome." European Respiratory Journal 33.3 (2009): 646-655. Web. 11 May. 2021.

  9. Robben, S. G.

    1. Been, J. V. et al "A 3-year-old female with cough, dyspnoea and low-grade fever." European Respiratory Journal 33.3 (2009): 690-693. Web. 11 May. 2021.

  10. Roca-Ferrer, J.

    1. Pujols, L. et al "Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo." European Respiratory Journal 33.3 (2009): 502-508. Web. 11 May. 2021.

  11. Rocco, P. R. M.

    1. Silva, P. L. et al "Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury." European Respiratory Journal 33.3 (2009): 634-645. Web. 11 May. 2021.

  12. Rooijackers, J.

    1. Pronk, A. et al "Different respiratory phenotypes are associated with isocyanate exposure in spray painters." European Respiratory Journal 33.3 (2009): 494-501. Web. 11 May. 2021.

  13. Röösli, M.

    1. Latzin, P. et al "Air pollution during pregnancy and lung function in newborns: a birth cohort study." European Respiratory Journal 33.3 (2009): 594-603. Web. 11 May. 2021.

  14. Rupprecht, L.

    1. Müller, T. et al "Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy." European Respiratory Journal 33.3 (2009): 551-558. Web. 11 May. 2021.

  15. Ruuskanen, O.

    1. Jartti, T., M. Korppi, and O. Ruuskanen. "The clinical importance of rhinovirus-associated early wheezing." European Respiratory Journal 33.3 (2009): 706-707. Web. 11 May. 2021.

S

  1. Salfield, N.

    1. Fogarty, A. W. et al "A natural experiment on the impact of fruit supplementation on asthma symptoms in children." European Respiratory Journal 33.3 (2009): 481-485. Web. 11 May. 2021.

  2. Sammani, S.

    1. Fu, P. et al "Amifostine reduces lung vascular permeability via suppression of inflammatory signalling." European Respiratory Journal 33.3 (2009): 612-624. Web. 11 May. 2021.

  3. Schaefer, I-M.

    1. Mühlfeld, C. et al "Pre-ischaemic exogenous surfactant reduces pulmonary injury in rat ischaemia/reperfusion." European Respiratory Journal 33.3 (2009): 625-633. Web. 11 May. 2021.

  4. Schmid, C.

    1. Müller, T. et al "Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy." European Respiratory Journal 33.3 (2009): 551-558. Web. 11 May. 2021.

  5. Schwartzman, K.

    1. Champagne, K. et al "Obstructive sleep apnoea and its association with gestational hypertension." European Respiratory Journal 33.3 (2009): 559-565. Web. 11 May. 2021.

  6. Scott, M.

    1. Scott, M. et al "Understanding the nature and outcome of childhood wheezing." European Respiratory Journal 33.3 (2009): 700-701. Web. 11 May. 2021.

  7. Sebire, N. J.

    1. Lumsden, D. E. et al "Pulmonary mass in an infant." European Respiratory Journal 33.3 (2009): 694-699. Web. 11 May. 2021.

  8. Séverin, T.

    1. Gappa, M. et al "Paediatric HERMES: update of the European Training Syllabus for Paediatric Respiratory Medicine." European Respiratory Journal 33.3 (2009): 464-465. Web. 11 May. 2021.

  9. Sheu, C. C.

    1. Sheu, C. C. et al "Sex-specific association of epidermal growth factor gene polymorphisms with acute respiratory distress syndrome." European Respiratory Journal 33.3 (2009): 543-550. Web. 11 May. 2021.

  10. Shim, Y-S.

    1. Hwang, S. S. et al "Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB." European Respiratory Journal 33.3 (2009): 581-585. Web. 11 May. 2021.

  11. Silva, P. L.

    1. Silva, P. L. et al "Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury." European Respiratory Journal 33.3 (2009): 634-645. Web. 11 May. 2021.

  12. Simonds, A. K.

    1. Jaye, J. et al "Autotitrating versus standard noninvasive ventilation: a randomised crossover trial." European Respiratory Journal 33.3 (2009): 566-571. Web. 11 May. 2021.

  13. Simonneau, G.

    1. Boutet, K. et al "Fenfluramine-like cardiovascular side-effects of benfluorex." European Respiratory Journal 33.3 (2009): 684-688. Web. 11 May. 2021.

  14. Sitbon, O.

    1. Boutet, K. et al "Fenfluramine-like cardiovascular side-effects of benfluorex." European Respiratory Journal 33.3 (2009): 684-688. Web. 11 May. 2021.

  15. Smith, R.

    1. Dwyer, N. et al "Granulomatous angiitis leading to a pulmonary veno-occlusive disease-like picture." European Respiratory Journal 33.3 (2009): 666-669. Web. 11 May. 2021.

  16. Sonnappa, S.

    1. Lumsden, D. E. et al "Pulmonary mass in an infant." European Respiratory Journal 33.3 (2009): 694-699. Web. 11 May. 2021.

  17. Stern, G.

    1. Thamrin, C. et al "Fluctuation analysis of lung function as a predictor of long-term response to β2-agonists." European Respiratory Journal 33.3 (2009): 486-493. Web. 11 May. 2021.

  18. Stradling, J. R.

    1. Ayers, L. et al "Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea." European Respiratory Journal 33.3 (2009): 574-580. Web. 11 May. 2021.

  19. Strippoli, M-P. F.

    1. Thamrin, C. et al "Fluctuation analysis of lung function as a predictor of long-term response to β2-agonists." European Respiratory Journal 33.3 (2009): 486-493. Web. 11 May. 2021.

  20. Su, L.

    1. Sheu, C. C. et al "Sex-specific association of epidermal growth factor gene polymorphisms with acute respiratory distress syndrome." European Respiratory Journal 33.3 (2009): 543-550. Web. 11 May. 2021.

  21. Suissa, S.

    1. Suissa, S.. " From the authors ." European Respiratory Journal 33.3 (2009): 709-710. Web. 11 May. 2021.

  22. Suki, B.

    1. Thamrin, C. et al "Fluctuation analysis of lung function as a predictor of long-term response to β2-agonists." European Respiratory Journal 33.3 (2009): 486-493. Web. 11 May. 2021.

  23. Sutedja, T.

    1. McWilliams, A., B. Lam, and T. Sutedja. "Early proximal lung cancer diagnosis and treatment." European Respiratory Journal 33.3 (2009): 656-665. Web. 11 May. 2021.

T

  1. Tanabe, T.

    1. Ito, M. et al "Central airway stenosis in a patient with autoimmune pancreatitis." European Respiratory Journal 33.3 (2009): 680-683. Web. 11 May. 2021.

  2. Taylor, D. R.

    1. Thamrin, C. et al "Fluctuation analysis of lung function as a predictor of long-term response to β2-agonists." European Respiratory Journal 33.3 (2009): 486-493. Web. 11 May. 2021.
    2. Taylor, D. R., and H. K. Reddel. " From the authors ." European Respiratory Journal 33.3 (2009): 706. Web. 11 May. 2021.

  3. Tejera, P.

    1. Sheu, C. C. et al "Sex-specific association of epidermal growth factor gene polymorphisms with acute respiratory distress syndrome." European Respiratory Journal 33.3 (2009): 543-550. Web. 11 May. 2021.

  4. Thamrin, C.

    1. Thamrin, C. et al "Fluctuation analysis of lung function as a predictor of long-term response to β2-agonists." European Respiratory Journal 33.3 (2009): 486-493. Web. 11 May. 2021.

  5. Theunissen, P.

    1. Been, J. V. et al "A 3-year-old female with cough, dyspnoea and low-grade fever." European Respiratory Journal 33.3 (2009): 690-693. Web. 11 May. 2021.

  6. Thompson, B. T.

    1. Sheu, C. C. et al "Sex-specific association of epidermal growth factor gene polymorphisms with acute respiratory distress syndrome." European Respiratory Journal 33.3 (2009): 543-550. Web. 11 May. 2021.

  7. Tortoli, E.

    1. Bartalesi, F. et al "QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases." European Respiratory Journal 33.3 (2009): 586-593. Web. 11 May. 2021.

  8. Tsushima, K.

    1. Ito, M. et al "Central airway stenosis in a patient with autoimmune pancreatitis." European Respiratory Journal 33.3 (2009): 680-683. Web. 11 May. 2021.

U

  1. Uehara, T.

    1. Ito, M. et al "Central airway stenosis in a patient with autoimmune pancreatitis." European Respiratory Journal 33.3 (2009): 680-683. Web. 11 May. 2021.

V

  1. Vainikka, L. K.

    1. Persson, H. L., and L. K. Vainikka. "Lysosomal iron in pulmonary alveolar proteinosis: a case report." European Respiratory Journal 33.3 (2009): 673-679. Web. 11 May. 2021.

  2. van Altena, R.

    1. Daniels, J. M. A. et al "Tuberculosis complicating imatinib treatment for chronic myeloid leukaemia." European Respiratory Journal 33.3 (2009): 670-672. Web. 11 May. 2021.

  3. van der Palen, J.

    1. Bourbeau, J., and J. van der Palen. "Promoting effective self-management programmes to improve COPD." European Respiratory Journal 33.3 (2009): 461-463. Web. 11 May. 2021.

  4. van Schayck, C. P.

    1. Quaak, M. et al "Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases?." European Respiratory Journal 33.3 (2009): 468-480. Web. 11 May. 2021.

  5. van Schooten, F. J.

    1. Quaak, M. et al "Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases?." European Respiratory Journal 33.3 (2009): 468-480. Web. 11 May. 2021.

  6. Venn, A. J.

    1. Fogarty, A. W. et al "A natural experiment on the impact of fruit supplementation on asthma symptoms in children." European Respiratory Journal 33.3 (2009): 481-485. Web. 11 May. 2021.

  7. Ventura, G. M.

    1. Silva, P. L. et al "Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury." European Respiratory Journal 33.3 (2009): 634-645. Web. 11 May. 2021.

  8. Vestbo, J.

    1. Keene, O. N. et al "Lung function decline in COPD trials." European Respiratory Journal 33.3 (2009): 708-709. Web. 11 May. 2021.

  9. Vicidomini, S.

    1. Bartalesi, F. et al "QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases." European Respiratory Journal 33.3 (2009): 586-593. Web. 11 May. 2021.

  10. Vollroth, M.

    1. Mühlfeld, C. et al "Pre-ischaemic exogenous surfactant reduces pulmonary injury in rat ischaemia/reperfusion." European Respiratory Journal 33.3 (2009): 625-633. Web. 11 May. 2021.

  11. Vonk-Noordegraaf, A.

    1. Daniels, J. M. A. et al "Tuberculosis complicating imatinib treatment for chronic myeloid leukaemia." European Respiratory Journal 33.3 (2009): 670-672. Web. 11 May. 2021.

W

  1. Wahlers, T.

    1. Mühlfeld, C. et al "Pre-ischaemic exogenous surfactant reduces pulmonary injury in rat ischaemia/reperfusion." European Respiratory Journal 33.3 (2009): 625-633. Web. 11 May. 2021.

  2. Wallis, C. E.

    1. Lumsden, D. E. et al "Pulmonary mass in an infant." European Respiratory Journal 33.3 (2009): 694-699. Web. 11 May. 2021.

  3. Wang, C.

    1. Zhou, Y. et al "COPD in Chinese nonsmokers." European Respiratory Journal 33.3 (2009): 509-518. Web. 11 May. 2021.
    2. Zhou, Y. et al "COPD in Chinese nonsmokers." European Respiratory Journal 33.3 (2009): 509-518. Web. 11 May. 2021.

  4. Wang, D.

    1. Zhou, Y. et al "COPD in Chinese nonsmokers." European Respiratory Journal 33.3 (2009): 509-518. Web. 11 May. 2021.

  5. Wang, X.

    1. Zhou, Y. et al "COPD in Chinese nonsmokers." European Respiratory Journal 33.3 (2009): 509-518. Web. 11 May. 2021.

  6. Weir, K.

    1. Weir, K. et al "Clinical signs and symptoms of oropharyngeal aspiration and dysphagia in children." European Respiratory Journal 33.3 (2009): 604-611. Web. 11 May. 2021.

  7. Wennergren, G.

    1. Bush, A. et al " To the Editors ." European Respiratory Journal 33.3 (2009): 705-706. Web. 11 May. 2021.

  8. Wildhaber, J. H.

    1. Gappa, M. et al "Paediatric HERMES: update of the European Training Syllabus for Paediatric Respiratory Medicine." European Respiratory Journal 33.3 (2009): 464-465. Web. 11 May. 2021.

  9. Willems, L.N.A.

    1. Willems, L.N.A.. "Textbook of Lung Cancer. Second Edition." European Respiratory Journal 33.3 (2009): 711. Web. 11 May. 2021.

  10. Wilson, N. M.

    1. Bush, A. et al " To the Editors ." European Respiratory Journal 33.3 (2009): 705-706. Web. 11 May. 2021.

  11. Wittwer, T.

    1. Mühlfeld, C. et al "Pre-ischaemic exogenous surfactant reduces pulmonary injury in rat ischaemia/reperfusion." European Respiratory Journal 33.3 (2009): 625-633. Web. 11 May. 2021.

  12. Wojarski, J.

    1. Jastrzebski, D. et al "Left ventricular dysfunction in patients with interstitial lung diseases." European Respiratory Journal 33.3 (2009): 702-703. Web. 11 May. 2021.

  13. Wouters, I. M.

    1. Pronk, A. et al "Different respiratory phenotypes are associated with isocyanate exposure in spray painters." European Respiratory Journal 33.3 (2009): 494-501. Web. 11 May. 2021.

  14. Wrede, C. E.

    1. Müller, T. et al "Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy." European Respiratory Journal 33.3 (2009): 551-558. Web. 11 May. 2021.

X

  1. Xing, J.

    1. Fu, P. et al "Amifostine reduces lung vascular permeability via suppression of inflammatory signalling." European Respiratory Journal 33.3 (2009): 612-624. Web. 11 May. 2021.

Y

  1. Yamamoto, H.

    1. Ito, M. et al "Central airway stenosis in a patient with autoimmune pancreatitis." European Respiratory Journal 33.3 (2009): 680-683. Web. 11 May. 2021.

  2. Yao, W.

    1. Zhou, Y. et al "COPD in Chinese nonsmokers." European Respiratory Journal 33.3 (2009): 509-518. Web. 11 May. 2021.

  3. Yasuo, M.

    1. Ito, M. et al "Central airway stenosis in a patient with autoimmune pancreatitis." European Respiratory Journal 33.3 (2009): 680-683. Web. 11 May. 2021.

  4. Yates, J. C.

    1. Keene, O. N. et al "Lung function decline in COPD trials." European Respiratory Journal 33.3 (2009): 708-709. Web. 11 May. 2021.

  5. Yim, J-J.

    1. Hwang, S. S. et al "Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB." European Respiratory Journal 33.3 (2009): 581-585. Web. 11 May. 2021.

  6. Yokoyama, T.

    1. Ito, M. et al "Central airway stenosis in a patient with autoimmune pancreatitis." European Respiratory Journal 33.3 (2009): 680-683. Web. 11 May. 2021.

  7. Yoo, C-G.

    1. Hwang, S. S. et al "Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB." European Respiratory Journal 33.3 (2009): 581-585. Web. 11 May. 2021.

Z

  1. Zach, M.

    1. Gappa, M. et al "Paediatric HERMES: update of the European Training Syllabus for Paediatric Respiratory Medicine." European Respiratory Journal 33.3 (2009): 464-465. Web. 11 May. 2021.

  2. Zembala, M.

    1. Jastrzebski, D. et al "Left ventricular dysfunction in patients with interstitial lung diseases." European Respiratory Journal 33.3 (2009): 702-703. Web. 11 May. 2021.

  3. Zhai, R.

    1. Sheu, C. C. et al "Sex-specific association of epidermal growth factor gene polymorphisms with acute respiratory distress syndrome." European Respiratory Journal 33.3 (2009): 543-550. Web. 11 May. 2021.

  4. Zheng, J.

    1. Zhou, Y. et al "COPD in Chinese nonsmokers." European Respiratory Journal 33.3 (2009): 509-518. Web. 11 May. 2021.

  5. Zhong, N.

    1. Zhou, Y. et al "COPD in Chinese nonsmokers." European Respiratory Journal 33.3 (2009): 509-518. Web. 11 May. 2021.

  6. Zhou, Y.

    1. Zhou, Y. et al "COPD in Chinese nonsmokers." European Respiratory Journal 33.3 (2009): 509-518. Web. 11 May. 2021.

  7. Zimmermann, M.

    1. Müller, T. et al "Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy." European Respiratory Journal 33.3 (2009): 551-558. Web. 11 May. 2021.

  8. Zin, W. A.

    1. Silva, P. L. et al "Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury." European Respiratory Journal 33.3 (2009): 634-645. Web. 11 May. 2021.

  9. Ziora, D.

    1. Jastrzebski, D. et al "Left ventricular dysfunction in patients with interstitial lung diseases." European Respiratory Journal 33.3 (2009): 702-703. Web. 11 May. 2021.

  10. Zivkovic, Z.

    1. Gappa, M. et al "Paediatric HERMES: update of the European Training Syllabus for Paediatric Respiratory Medicine." European Respiratory Journal 33.3 (2009): 464-465. Web. 11 May. 2021.
Back to top
European Respiratory Journal: 33 (3)

Search Within This Issue

Jump to

Manage Table of content Alerts